Decreasing ventilator-associated pneumonia in a trauma ICU

Journal of Trauma - Injury, Infection and Critical Care

Volumn 61, Issue 1, 2006, Pages 122-129

  Cocanour, Christine S ^a,c   Peninger, Michelle ^b   Domonoske, Bradley D ^b   Li, Tao ^b   Wright, Bobbie ^b   Valdivia, Alicia ^b   Luther, Katharine M ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MEMORIAL HERMANN HOSPITAL   (United States)

^c MSB 4284 ^*  (United States)

Author keywords

Ventilator bundle; Ventilator associated pneumonia

Indexed keywords

ARTICLE; CAREGIVER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HOSPITAL INFECTION; HOSPITAL MANAGEMENT; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL STAFF; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRAUMATOLOGY; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

CRITICAL PATHWAYS; CROSS INFECTION; GUIDELINE ADHERENCE; HOSPITAL COSTS; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; MEDICAL AUDIT; PNEUMONIA; QUALITY ASSURANCE, HEALTH CARE; RESPIRATION, ARTIFICIAL; TEXAS;

EID: 33746257403     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000223971.25845.b3     Document Type: Article

References (25)

1. Berenholtz SM, Dorman T, Pronovost PJ. Improving quality and safety in the ICU. Contemp Crit Care. 2003;1:1-8.
2. Drakulovic MB, Torres A, Bauer TT, et al. Supine body posit ion as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet. 1999;354:1851-1858.
3. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation: Canadian Critical Care Trials Group. N Engl J Med. 1998;338:791-797.
4. Attia J, Ray JG, Cook DJ, Couketis J, et al. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001;161:1268-1279.
5. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471-1477.
6. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: Mosby; 1996:A-1-A-20.
7. Guidelines for Prevention of Nosocomial Pneumonia. MMWR January 3, 1997;46;1-79.
8. Van Den Berghe G, Wouter P, Weekers F, et al. Intensive insulin therapy in critically ill patients. New Engl J Med. 2001;345:1359-1367.
9. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System. Am J Med. 1991:91(Suppl 3B):185S-91S.
10. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest. 2001;120:555-561.
11. George DL, Falk PS, Wunderink RG, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med. 1998;158:1839-1847.
12. Craven DE, Steger KA. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin Respir Infect. 1996;11:32-53.
13. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-288.
14. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159:1249-1256.
15. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosop Epidemiol. 1996;17:552-557.
16. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia: attributable mortality and morbidity. Am J Epidemiol. 1989;129:1258-1267.
17. Haley RW, White JW. Culver DH. Hughes JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: an empirical determination from a nationally representative sample. JAMA. 1987;257:1611-1614.
18. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312-1317.
19. CDC Guidelines for Prevention of Nosocomial Pneumonia. MMWR. 1997;46:1-79.
20. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med. 1999;340:627-634.
21. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003;138:494-501.
22. Orozco-Levi M, Torres A, Ferrer M, et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med. 1994;152:1387-1390.
23. Torres A, Serra-Batlles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med. 1992;116:540-543.
24. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alterenative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med. 1992;327:88-93.
25. Klein BS, Perloff WH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med. 1989;320:1714-1721.